Melanoma risk declines with self-exams plus doctor visit

Melanoma risk declines with self-exams plus doctor visit
Risk of deeper melanomas is reduced with self-examination of the skin one to 11 times a year, according to a study published online Aug. 16 in the British Journal of Dermatology.

(HealthDay)—Risk of deeper melanomas is reduced with self-examination of the skin one to 11 times a year, according to a study published online Aug. 16 in the British Journal of Dermatology.

Linda J. Titus, Ph.D., from the Dartmouth-Hitchcock Medical Center in Lebanon, N.H., and colleagues analyzed data from a population-based case-control study (423 cases and 678 controls) to assess recent skin self-examination in relation to self-detection, risk, and tumor depth.

The researchers found that skin self-examination conducted one to 11 times during a recent year was associated with a possible decrease in melanoma risk (odds ratio [OR], 0.74). For those who conducted skin self-examination and saw a doctor, the melanoma risk was significantly decreased (OR, 0.54). Among those patients with melanoma, those who examined their skin were twice as likely to self-detect the melanoma (OR, 2.23), but self-detection was not associated with shallower tumors. For those who conducted skin self-examination one to 11 times during a recent year, tumor depth was significantly reduced (OR, 0.39), but was not influenced by seeing a doctor or by conducting skin self-examination combined with seeing a doctor.

"Risk of a deeper and possibly risk of melanoma were reduced by self-examination one to 11 times annually," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Risk of second primary melanoma up in pediatric patients

Jun 28, 2012

(HealthDay) -- Pediatric patients diagnosed with an invasive cutaneous melanoma have nearly double the relative risk of developing a subsequent primary melanoma, compared with adults, according to a study ...

Recommended for you

Gene test aids cancer profile

15 hours ago

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.